Jacob Vincent Micallef, Chief Scientific Officer of VolitionRx Ltd. ($VNRX), made one open market purchase of company shares in the last year, totaling $21,500, with the most recent on May 19, 2025. This ranks him 3,761st out of 4,983 insiders by purchase amount, below the average of $1.46 million across about 3.3 transactions. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | F | Common Stock | 5310 | $0.19 | 665,292.0000 | 122,801,572 | 0.79% | 0.00% |
| Feb. 26, 2026 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | A | Common Stock | 149000 | $0.00 | 670,602.0000 | 122,801,572 | 28.57% | 0.12% |
| Jan. 22, 2026 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | A | Common Stock | 35400 | $0.00 | 521,602.0000 | 122,801,572 | 7.28% | 0.03% |
| Oct. 4, 2025 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | F | Common Stock | 5850 | $0.65 | 486,202.0000 | 96,543,744 | 1.19% | 0.01% |
| Sept. 28, 2025 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | F | Common Stock | 5568 | $0.61 | 492,052.0000 | 96,543,744 | 1.12% | 0.01% |
| June 1, 2025 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | F | Common Stock | 21526 | $0.50 | 497,620.0000 | 96,543,744 | 4.15% | 0.02% |
| May 19, 2025 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | P | Common Stock | 50000 | $0.43 | 519,146.0000 | 96,543,744 | 10.66% | 0.05% |
| May 1, 2025 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | F | Common Stock | 18319 | $0.49 | 469,146.0000 | 96,543,744 | 3.76% | 0.02% |
| Jan. 29, 2025 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 29, 2025 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | P | Common Stock | 43691 | $0.57 | 487,465.0000 | 0 | 9.85% | 0.00% |
| Oct. 4, 2024 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | F | Common Stock | 5200 | $0.88 | 443,774.0000 | 0 | 1.16% | 0.00% |
| Sept. 28, 2024 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | F | Common Stock | 4950 | $0.58 | 448,974.0000 | 0 | 1.09% | 0.00% |
| Sept. 1, 2024 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | A | Common Stock | 47837 | $0.00 | 453,924.0000 | 0 | 11.78% | 0.00% |
| Aug. 15, 2024 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | A | Common Stock | 13750 | $0.00 | 406,087.0000 | 0 | 3.50% | 0.00% |
| June 1, 2024 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | A | Common Stock | 40709 | $0.00 | 392,337.0000 | 0 | 11.58% | 0.00% |
| Jan. 24, 2024 | VOLITIONRX LTD | $VNRX | Micallef Jacob Vincent | Chief Scientific Officer | A | Common Stock | 23375 | $0.00 | 351,628.0000 | 0 | 7.12% | 0.00% |